Transitional Drugs
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)contractFind a Tender ↗Ref ocds-h6vhtk-034a9032014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
5
1 SME
Lots
1
5 awarded
Published
11 Oct 2022
Description
Transitional Drugs
Scope
- Reference
- ocds-h6vhtk-034a90
- Commercial tool
- Standalone contract
- Contract dates
- 30 Sept 2022 to 31 Jan 2024
There is a possibility to extend up to a further 12 months
- Main category
- goods
- Contract locations
- Wales
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | Pass/Fail | quality | — |
| Price | 30 | quality | — |
| VFM | 20 | cost | — |
| Price Stability | 6 | cost | — |
| Minimum Order | 4 | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 5 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Award 1· 1 supplier
Awarded —
Award value
—
Award 2· 1 supplier
Awarded —
Award value
—
Award 3· 1 supplier
Awarded —
Award value
—
Award 4· 1 supplier
Awarded —
Award value
—
Award 5· 1 supplier
Awarded —
Award value
—
Other contracts from Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Glenmark Pharmaceuticals· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NP36126 Antibiotic & Genito Urinary Medicines | contract | — | 25 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 22 May 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 30 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines | contract | — | 06 Jan 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 26 Nov 2025 |